USPSTF screening ages
Screening is recommended for average-risk adults in this age range. Positive non-invasive tests require colonoscopy for the benefit to be achieved.
See reference 1 ↓A colorectal cancer follow-up initiative
Every positive non-invasive colorectal cancer screening test should be followed by a timely diagnostic colonoscopy. Yet many patients never complete this critical next step. ColonOwl is working to better understand this challenge and explore technology-enabled approaches that support patients, providers, and health plans.
Share your experience with colorectal cancer screening follow-up in a confidential 25-minute conversation.
Select several possible times—we’ll confirm one by email.
patients with a positive FIT
was associated with nearly twice the odds of advanced-stage colorectal cancer compared with follow-up within 30 days.
The screening journey
Why follow-up matters
An abnormal non-invasive screening result is not a diagnosis. Colonoscopy is the essential next step that allows clinicians to find the cause, identify cancer, or remove precancerous growths.
Screening is recommended for average-risk adults in this age range. Positive non-invasive tests require colonoscopy for the benefit to be achieved.
See reference 1 ↓In a large U.S. cohort, colonoscopy 10–12 months after a positive FIT was associated with nearly twice the odds of advanced-stage colorectal cancer compared with follow-up within 30 days.
See reference 2 ↓NCQA’s draft MY 2027 measure evaluates colonoscopy completion within 180 days after a positive non-invasive test.
See reference 3 ↓Statistics describe published evidence and the measurement landscape—not ColonOwl outcomes.
U.S. Preventive Services Task Force. Colorectal Cancer: Screening. Recommendation statement, May 2021.
Corley DA, Jensen CD, Quinn VP, et al. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017;317(16):1631–1641.
National Committee for Quality Assurance. Colorectal Cancer Screening Follow-Up (COF-E), draft MY 2027 specification. Draft measure document.
One gap, many perspectives
The journey crosses organizational boundaries. Understanding each perspective is the starting point for meaningful improvement.
A positive result can create uncertainty. Clear next steps, timely follow-up, and coordinated support matter on the path to diagnosis.
Current research focusReferral leakage, manual navigation, scheduling bottlenecks, fragmented workflows, and capacity constraints can all interrupt follow-up.
Current research focusQuality measurement is evolving. NCQA is developing COF-E to evaluate colonoscopy completion after a positive non-invasive screening test.
Current research focusWhy now
Non-invasive tests offer a practical path to reach more eligible adults.
The benefit of screening depends on what happens after an abnormal result.
COF-E reflects growing attention to timely diagnostic follow-up.
Data, automation, and carefully applied AI may help care teams understand and improve workflows.
Our mission
ColonOwl was created to better understand why patients are still lost after abnormal colorectal cancer screening—and to explore practical, technology-enabled approaches that improve follow-up.
Our current focus is listening to clinicians, quality leaders, health systems, gastroenterologists, and health plans.
Participate in the research
We’re interviewing population health leaders, quality executives, gastroenterologists, nurse navigators, care coordinators, health plan leaders, and clinical informatics professionals.
Select several times that work for you. We’ll confirm one by email.